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In their otherwise informative and concise
review of the current state of evidence con-
cerning risk factors for acute childhood
leukemia, Belson et al. (2007) did not cor-
rectly address nonionizing radiation and, in
particular, power frequency magnetic fields
as a possible risk factor for childhood
leukemia. This failure may be due to a
widespread misconception about the evi-
dence concerning nonionizing electro-
magnetic fields (EMFs) as a health hazard.
It is also apparent in the Churchill County
leukemia cluster study published in the
same issue, in which Rubin et al. (2007)
investigated a multitude of factors, many
with sparse or ambiguous previous evidence
of an association with childhood leukemia.
Although power frequency magnetic fields
have been classified as a possible human
carcinogen (group 2B) by the International
Agency for Research on Cancer (IARC
2002) and by a National Institute of
Environmental Health Sciences (NIEHS)
working group (NIEHS 1998), based on
the evidence of an association with child-
hood leukemia, these were apparently not
considered by Rubin et al. (2007).
In their review of nonionizing radiation,
Belson et al. (2007) inappropriately mixed
original research and pooled analyses, fur-
ther contributing to the prevailing confu-
sion. Both Ahlbom et al. (2000) and
Greenland et al. (2000) presented pooled
analyses that included the important study
of Linet et al. (1997). Hence, it is inappro-
priate to present results of the latter as an
independent source. Almost all epidemio-
logic studies of residential exposure to power
frequency magnetic fields published before
1999 are included in either the pooled
analyses of Ahlbom et al. (2000) or
Greenland et al. (2000). Only the study of
Myers et al. (1990) was not included
because authors refused to provide requested
data. Although the study of Linet et al.
(1997) is often cited as failing to support the
hypothesis of an association between resi-
dential exposure to magnetic fields and
childhood leukemia [it was also cited by
Belson et al. (2007)], it actually was one of
the most important supporters of an associa-
tion in the pooled analyses and contributed
the greatest number of highly exposed chil-
dren. Two large and well-conducted studies
published after the pooled analyses (Kabuto
et al. 2006; Schüz et al. 2001) lend further
support to the results of the pooled analyses
of an increased risk from high average levels
of magnetic field exposure.
It is also incorrect to characterize the
evidence as “some have found a small asso-
ciation … while others have not ….” First
of all, the association is not small, but is
comparable or larger than that for all other
factors considered by Belson et al. (2007).
Second, the evidence is consistent across
different continents, study types, measure-
ment methods, and other factors. Of
course, there are potential sources of bias, in
particular selection bias. However, thor-
ough investigations of these potential biases
have rendered it unlikely that they can
completely explain the association. Up to
now, there is no other risk factor of child-
hood leukemia that has been as comprehen-
sively studied concerning possible biases
and confounding factors.
It is high time that exposure to power
frequency EMFs is recognized as a potential
risk factor for childhood leukemia and is
properly included in the protocols of cluster
studies and in epidemiologic studies of other
risk factors as a potential confounder.
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Editor’s note: In accordance with journal
policy, Belson et al. were asked whether they
wanted to respond to this letter, but they chose
not to do so.
Ionizing Radiation and
Childhood Leukemia
doi: 10.1289/ehp.10080
I read with interest the recent review by
Belson et al. (2007) on childhood leukemia,
particularly the sections dealing with radia-
tion exposure. Like the authors, I believe
that ionizing radiation is strongly associated
with childhood acute leukemia. I would like
to point out that several critical pieces of
information were overlooked; these support
stronger and more meaningful conclusions. 
Although atomic bomb survivors offer
the clearest evidence of leukemia risk after
childhood exposures to ionizing radiation,
studies of children exposed to fallout in
other contexts should not be downplayed.
Belson et al. (2007) stated that “radiation
exposure secondary to the Chernobyl acci-
dent has not been shown to increase the
risk of leukemia in children who were
exposed after birth …,” but they failed to
mention the case–control study of
Noshchenko et al. (2002), which found sig-
nificant increases in childhood and acute
leukemias in association with estimated
childhood exposures. Children living down-
wind of the Nevada Test Site have also
shown a significant increase in leukemia
related to estimated fallout exposure
(Stevens et al. 1990).
In utero exposure to ionizing radiation
has been a known causal factor for child-
hood cancer for > 50 years. Although Belson
et al. (2007) stated that the lack of evidence
for a childhood leukemia risk among atomic
bomb survivors constitutes the “most
notable reason for doubt of a true associa-
tion,” they overlooked the reviews of
Wakeford and Little (2002, 2003); these
authors demonstrated that the highly uncer-
tain atomic bomb survivor data are statisti-
cally compatible with the robust set of data
found in the Oxford Survey of Childhood
Cancers and related X-ray exposure cohorts.
There is no valid reason to doubt this
association at present.
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The association between preconception
paternal irradiation (PPI) and childhood
leukemia has always been controversial. Two
of the major objections to the “Gardner
hypothesis,” as Belson et al. (2007) pointed
out, have been mixed evidence from studies
of radiation-exposed fathers and a lack of
positive evidence in the children of the
atomic bomb survivors. Regarding the first
objection, Belson et al. overlooked the two
largest studies of the children of radiation
workers. Draper et al. (1997) conducted a
UK-wide case–control study of childhood
cancers in relation to paternal radiation expo-
sure. This study showed, based on > 13,000
cases not included in the study of Gardner
et al. (1990), that children with leukemia or
non-Hodgkin lymphoma were significantly
more likely than controls to have fathers who
were radiation workers. Dickinson and
Parker (2002) conducted a cohort study of
> 250,000 births in Cumbria, England,
including the cases of Gardner et al. (1990),
and found a significant 2-fold increase in the
risk of leukemia and non-Hodgkin lym-
phoma among the children of radiation
workers. These and other studies, taken
together, give statistical support to the idea
that paternal radiation work is a risk factor
for childhood leukemia. 
When interpreting the evidence for a PPI
effect in atomic bomb survivors, it is impor-
tant to consider what is known about poten-
tial mechanisms. As reviewed by Niwa
(2003), Nomura (2003), and others, animal
studies have consistently demonstrated that
PPI can cause or increase the susceptibility to
leukemia in offspring. In addition to fasci-
nating evidence of postconception genomic
instability after preconception exposure,
many studies suggest that there may a win-
dow of sensitivity corresponding to post-
meiotic stages of spermatogenesis; in
humans, this would mean the few months
leading up to conception (Adler 1996). Of
the roughly 30,000 children of atomic bomb
survivors, only about 2% were conceived in
the 6 months after the bombings. Based on
the spontaneous leukemia rate reported by
Yoshimoto (1990), the expected number of
spontaneous cases in this subcohort would
be < 1, and an excess on the order suggested
by the radiation worker studies would not be
statistically apparent. For this and other rea-
sons, the atomic bomb survivors may not be
an appropriate comparison group. 
To summarize, it is not unreasonable to
observe that the weight of evidence generated
to date supports the idea that preconception,
prenatal, and postnatal exposures to ionizing
radiation are all risk factors for childhood
leukemia.
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Methylmercury and the
Developing Brain 
doi: 10.1289/ehp.10302
We reported that prenatal exposure to
methylmercury causes cognitive impair-
ment in an estimated 316,588 children
born in the United States each year, costing
this nation $8.7 billion annually in lost pro-
ductivity (Trasande et al. 2005). Each year,
this exposure also causes an estimated 1,566
cases of mental retardation (Trasande et al.
2006). The principal (70%) source of the
mercury that enters the bodies of American
children is combustion of coal in electricity-
generating plants.
In their reanalysis of our data, Griffiths
et al. (2007) made a series of incorrect judg-
ments and poorly considered assumptions,
each of which diminishes the import of our
findings. We note the following errors in
their analysis:
First, Griffiths et al. (2007) incorrectly
used a linear model to relate cognitive func-
tion to prenatal methylmercury exposure,
despite the National Research Council’s
(NRC) clear finding that a logarithmic
model provides a better statistical fit. The
NRC, in their examination of the Faroe
Islands cohort study, the study on which
they place greatest reliance, stated that
“[b]ecause these calculations necessitate
extrapolating to estimate the mean response
at zero exposure level,” logarithmic models
“lead to lower estimates of the Benchmark
Dose (BMD) than linear or K-power 
models” (NRC 2000, p. 294).
Recent analyses of early childhood lead
exposure further corroborate the validity of
logarithmic models in representing subclini-
cal dose–response relationships of neuro-
developmental injury (Canfield et al. 2003).
Second, Griffiths et al. (2007) unwisely
based their analysis on potentially biased
data from the Seychelles cohort study. By
contrast, our model (Trasande et al. 2005),
like that of the NRC, is based primarily on
Faroes data. We chose not to use Seychelles
data because of concern that the tests of
neurobehavioral function used there were
not well validated for a non-American
population and therefore may not have
been sensitive to detect cognitive impair-
ment (Landrigan and Goldman 2003).
Another major potential source of bias in
the Seychelles study, not acknowledged by
Griffiths et al. (2007), is that it fails to con-
sider the potentially beneficial nutrients
found in the fish-based diet of the Seychelles.
These nutrients, omega-3 fatty acids in par-
ticular, may partially offset the toxicity of
methylmercury. Indeed, if maternal fish
intake is taken into account in the Seychelles
cohort, as recently was done, the estimate of
methylmercury toxicity increases (Budtz-
Jorgensen et al. 2007).
Griffiths et al. (2007) cited previous
meta-analyses of the Faroes, Seychelles, and
New Zealand studies by Ryan (2005) in
applying IQ decrements of 0.13–0.18
points/ppm hair mercury, but these are
likely underestimates, and further invalidate
the analysis of Griffiths et al. 
Third, in attributing mercury deposition
to sources of emission, Griffiths et al. (2007)
relied inexplicably and without justification
on a mathematical model that posits that
only 16% of deposits are attributable to
American sources. They ignored empiric data
from the U.S. Environmental Protection
Agency (EPA)-sponsored Steubenville study,
which found that 80–90% of mercury emis-
sions deposit within 30–50 miles of the
source (U.S. EPA 2007); and from theEnvironmental Health Perspectives • VOLUME 115 | NUMBER 8 | August 2007 A 397
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Electric Power Research Institute, which esti-
mated that 30% of mercury deposits are
attributable to American sources (Seigneur
et al. 2004).
Fourth, Griffiths et al. (2007) incor-
rectly assumed that reductions in mercury
emissions from power plants do not result in
any reduced levels of fish contamination
until after 15 years. This is not correct.
Reductions in power-plant emissions in
2008 will, in fact, begin immediately to
minimize methylmercury body burden
among children born to women in 2008,
and the degree of reduction will increase fur-
ther in subsequent years, perhaps through
2038, thus reducing the number of children
damaged, the severity of the prenatal brain
damage in these children, and the resulting
economic burden.
Finally, Griffiths et al. (2007) incorrectly
based their estimate of the economic value
of a child’s social productivity on the 1992
Current Population Survey rather than on
the currently available 2005 data set. This
miscalculation substantially underestimates
the economic impact of methylmercury on
the developing brain. Viscusi and Aldy
(2004) estimated that this value is currently
on the order of $4–9 million/child, a value
far greater than that used by Griffiths et al.,
and greater even than our estimate.
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Methylmercury and the Brain:
Griffiths et al. Respond
doi: 10.1289/ehp.10302R
In our review of the article by Trasande
et al. (2005), we used their published linear
model to evaluate the monetized impact of
IQ decrements associated with prenatal
mercury exposure to methylmercury
(MeHg) under different assumptions
(Griffiths et al. 2007). First, we used a cor-
rected dose–response slope to address the
error that the authors made in the conver-
sion of the relationship between cord blood
and neurodevelopment effects. We then
introduced the assumptions that the U.S.
Environmental Protection Agency (EPA)
used in its Clean Air Mercury Rule (CAMR).
Introducing the U.S. EPA assumptions
decreased the undiscounted monetized
impact of global anthropogenic mercury
emissions in the corrected Trasande et al.
model by 81% and decreased the estimated
impact of U.S. sources by almost 97%.
When discounting is included, the U.S.
EPA assumptions decreased the monetized
estimate of global impacts by 88% and the
impact of U.S. power plants by 98%.
The choice of a linear model (i.e., a
K-power model, with K = 1) was based on
the recommendation of the National
Research Council (NRC 2000):
After extensive discussion, the committee con-
cluded that the most reliable and defensible
results for the purpose of risk assessment are
those based on the K-power model. 
Trasande et al. choose to emphasize the
results of their logarithmic model, which
produces their highest estimates of mone-
tized impacts. We do not dispute that there
may be cases in which a logarithmic model
might be appropriate, but in the case of
methylmercury, the NRC (2000) was
unequivocal: 
For MeHg, the committee believes that a good
argument can be made for the use of a K-power
model with K constrained to be greater than or
equal to 1. That rules out square-root (K = 0.5) and
log models (the limiting case as K approaches 0).
For the U.S. EPA dose–response slope,
we used the results of an integrated statisti-
cal analysis by Ryan (2005), which has been
recently updated (Axelrad et al. 2007). The
analysis of Axelrad et al. includes results
from the Seychelles study and also those of
the Faroe Islands study (which was used by
Trasande et al. 2005), as well as the New
Zealand study. All three of these studies
were used by the NRC (2000) and are
described as being “well designed and care-
fully conducted, and each examined prena-
tal MeHg exposures within the range of the
general U.S. population exposures.” We will
concede that controlling for maternal fish
intake when assessing the impact of mer-
cury on neurodevelopment is an important
consideration that can be addressed in the
future.
The assumption that, on average, 16%
of the total mercury deposition in the
United States is from American and
Canadian sources comes straight from the
U.S. EPA model used for the CAMR. As
discussed in our article (Griffiths et al.
2007), the U.S. EPA used a spatially
explicit air quality model to simulate the
location of mercury deposition, but we used
the average value to compare it to Trasande
et al.’s (2005) assumption that 60% of the
mercury content in all domestically caught
fish is due to American sources. It is true
that in the study of Steubenville, Ohio,
published after the CAMR was promul-
gated, Keeler (2006) found a much higher
percentage of local and regional deposition
(70% of the mercury wet deposition, not
80–90%), but this is an estimate of deposi-
tion at a single point and cannot be extrap-
olated to the entire country. Furthermore,
the same U.S. EPA model that produced
the 16% average value predicts compara-
tively high values for the Steubenville
region of Ohio (U.S. EPA 2006).
With regard to the charge that we
assumed there will be no reductions in
fish contamination until after 15 years,
Transande et al. are wrong. In our article
(Griffiths et al. 2007) we are clear in our
position that benefits build over time dur-
ing the transition path from the current
conditions to the new equilibrium. The
choice of 15 years is an average period over
which to discount the benefits, reflecting
the 5–30 years for freshwater systems and
the 30–200 years for ocean systems to reach
equilibrium. Furthermore, we reported the
undiscounted monetized results, which
could be compared to Trasande et. al’s
(2005) implicit assumption of the instanta-
neous elimination of all anthropogenic mer-
cury from the environment.
Finally, Trasande et al.’s reference to
Viscusi and Aldy (2004) is truly baffling.A 398 VOLUME 115 | NUMBER 8 | August 2007 • Environmental Health Perspectives
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That article is a review and evaluation of
dozens of studies on the value of a statistical
life (VSL). A VSL is derived from the trade-
offs witnessed in the market and elsewhere
between income and small changes in risk
of death. The value for a small change in
mortality risk is aggregated to statistical
lives in order to be comparable to risk
assessment estimates. Because mortality risk
and IQ decrements are vastly different
items, there is no expected relationship
between these two values. 
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Environmental Exposures and
ADHD
doi: 10.1289/ehp.10274
In their article, “Exposures to Environ-
mental Toxicants and Attention Deficit
Hyperactivity Disorder [ADHD] in U.S.
Children,” Braun et al. (2006) advanced our
knowledge of the effects of environmental
tobacco smoke (ETS) and lead on the cen-
tral nervous system of children. With respect
to lead exposure, the study, importantly,
focused on an older age group (4–15 years)
than is generally studied (< 6 years) because
of the greater sensitivity of the developing
central nervous system to environmental
insult early in life [Centers for Disease
Control and Prevention (CDC) 1997]. 
In the logistic model used by Braun
et al. (2006), the association of ADHD with
lead exposure was statistically significant in
the highest exposure quintile; however, it
was also tenuous. Although not unheard of,
the cutoff (p < 0.2) for inclusion of factors
and variables associated with ADHD on
univariate analysis was generous compared
with the commonly used 0.1 or 0.05, and
very close to the p-value of the lead–ADHD
association of 0.19. The lead–ADHD rela-
tionship also exhibited a significant monoto-
nic dose response, so it would have been
helpful to know how the authors developed
their exposure metric. Why, for example,
were quintiles selected rather than another
interval scheme, and why were they not of
uniform size? Was the reported dose
response the only model considered, or did
the authors investigate other models, as
some have done in studying the relationship
of lead exposure and cognition (Canfield
et al. 2003)?
Braun et al. (2006) noted that their
analyses were limited by the cross-sectional
nature of the National Health and Nutrition
Examination Survey data they used, preclud-
ing adjustment of their model for certain
covariates and potential confounders (e.g.,
parental psychopathology). Based on data
from multiple studies, ADHD heritability
has been estimated to be about 75%
(Biederman and Faraone 2005). Inability to
adjust for parental psychopathology is there-
fore an important limitation, because adjust-
ment would likely reduce—and might
eliminate—the associations of ADHD with
ETS and lead. In studies of lead exposure
and cognition, some of which Braun et al.
(2006) cited as being consistent with their
findings, the strength of the IQ–lead
relationship can be dwarfed by the relation-
ship of IQ to other factors such as parenting
and socioeconomic status (Koller et al.
2004). When reporting associations of
environmental contaminants and pathology,
it seems prudent to maintain a broader per-
spective, as well as an environmental health
perspective. 
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We read with special interest the article by
Braun et al. (2006). In this large survey, the
authors concluded that prenatal exposure to
tobacco and environmental lead are risk fac-
tors for attention deficit hyperactivity dis-
order (ADHD).
We would like to focus on the potential
neuroprotective role of iron against the
deleterious effect of lead on the develop-
ment of ADHD symptoms.
Although the mechanisms underlying
ADHD remain unclear, both genetic and
environmental factors have been implicated.
In a recent review on the implication of the
dopaminergic system in the etiology of
ADHD, Swanson et al. (2007) highlighted
the importance of environmental risk fac-
tors as possible etiologies of dopamine
deficit. Among these environmental factors,
Swanson et al. (2007) cited the effects of lead
exposure (at levels < 10 µg/dL) on ADHD-
related behaviors and ADHD diagnosis. 
Lead in the central nervous system may
contribute to dopaminergic dysfunction
inducing alteration of dopamine release and
dopamine receptor density (Gedeon et al.
2001; Lidsky et al. 2003). Moreover, lead
may disrupt the structure of the blood–brain
barrier function essential for brain integrity
(Dyatlov et al. 1998). Interestingly, Wang
et al. (2007) recently reported that iron sup-
plementation protects the integrity of the
blood–brain barrier against lead insults. On
the other hand, iron deficiency could
increase the toxic effect of lead, suggesting a
potent neuroprotective effect of iron supple-
mentation on dopaminergic dysfunction
due to lead exposure (Wright 1999; Wright
et al. 2003) 
In a controlled comparison group study,
we (Konofal et al. 2004) showed that iron
deficiency was correlated to ADHD symp-
toms severity, hypothesizing that iron supple-
mentation may improve symptoms ofEnvironmental Health Perspectives • VOLUME 115 | NUMBER 8 | August 2007 A 399
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ADHD in those subjects with low ferritin
levels.
Given that lead exposure may contribute
to ADHD and iron deficiency may exacer-
bate deleterious effects caused by lead, we
recommend systematically seeking for iron
deficiency in children with ADHD. We also
think that controlled studies assessing the
potential effectiveness of iron supplementa-
tion on ADHD symptoms should be
encouraged. Such studies could aid the
understanding of the complex pathophysiol-
ogy underlying ADHD and provide effective
therapeutic strategies for this disorder. 
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We appreciate the comments of Brondum,
and Konofal and Cortese, and the opportu-
nity to clarify our results (Braun et al. 2006).
It is common practice to select variables with a
p-value of 0.2 for inclusion in multivariable
models (Katz 1999). Although the association
of blood lead levels and ADHD appeared
“tenuous” in bivariate analysis (i.e., p = 0.19),
this was largely an artifact of our decision to
categorize blood lead levels. When we entered
lead into our multivariable analysis as a con-
tinuous variable, we found a 1.2-fold
increased odds [95% confidence interval (CI),
1.0–1.4; p = 0.02] of ADHD for each
1.0-µg/dL increase in blood lead levels. The
blood lead quintiles were not divided into
exactly equal sample sizes because we used
weighted percentages to categorize the data.
We decided a priori to present the analysis in
quintiles to make the results easier to interpret
and also to illustrate any dose–response rela-
tionships for blood lead levels and ADHD.
As we noted in the “Discussion” of our
article (Braun et al. 2006), a limitation of
our study was the inability to adjust for
parental psychopathology. This is an unfor-
tunate trade-off when using a large nationally
representative survey. In other studies, prena-
tal tobacco exposure has been shown to be a
risk factor for the development of ADHD
after controlling for parental psycho-
pathology (Mick et al. 2002; Weissman et al.
1999). Although there is considerable experi-
mental and epidemiologic evidence linking
lead exposure with behaviors consistent with
ADHD, future studies of childhood lead
exposure will need to confirm our results by
accounting for parental psychopathology and
other potential confounders. 
The hypothesis proposed by Konofal and
Cortese—that iron deficiency may play a role
in symptom severity among children with
ADHD—is intriguing. Indeed, it was their
original research that prompted us to incor-
porate ferritin as a measure of iron status
(Konofal et al. 2004). It is certainly plausible
that iron deficiency may confound or modify
the effects of environmental lead exposure on
ADHD in children. Alternatively, lead expo-
sure may act as a confounder or modifier for
the observed effects of iron deficiency with
ADHD. Unfortunately, we were not able to
examine whether ferritin (or other indicators
of iron status) was associated with ADHD
symptom severity using the National Health
and Nutrition Examination Survey. Nor did
we specifically test for an association between
iron deficiency and ADHD. Although iron
or other micronutrient supplementation may
protect children from lead toxicity, recent evi-
dence from a double-blind randomized trial
(Kordas et al. 2005) suggests that iron and
zinc supplementation did not appreciably
lower blood lead levels or improve child
behavior, as measured by the Conners Rating
Scales. However, Kordas et al. included only
children without anemia in their trial. 
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ERRATUM
In the article by O’Neil [Environ Health
Perspect 115:1087–1093 (2007)], the cor-
responding author’s address is incorrect.
The correct address is S.G. O’Neil, 1071
Blue Hill Ave., Milton, MA 02186.
Telephone: 617-333-0500. E-mail:
soneil0905@curry.edu
EHP regrets the error.